Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
California Resources
CRC
$4.69B
| $28.8M | ﹤0.01% |
643,847
-17,111
| -3% | -$812K |
|
|
OXLC
2602
Oxford Lane Capital
OXLC
$950M
| $28.8M | ﹤0.01% |
1,965,318
+579,403
| +42% | +$8.67M |
|
2603
Melco Resorts & Entertainment
MLCO
$2.14B
| $28.8M | ﹤0.01% |
3,798,657
+296,277
| +8% | +$2.49M |
|
2604
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.59B
| $28.7M | ﹤0.01% |
164,826
-80,867
| -33% | -$13.9M |
|
2605
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $28.7M | ﹤0.01% |
1,283,715
-15,225
| -1% | -$346K |
|
2606
VanEck Pharmaceutical ETF
PPH
$991M
| $28.6M | ﹤0.01% |
277,606
-377,981
| -58% | -$36.8M |
|
2607
Walker & Dunlop
WD
$1.47B
| $28.6M | ﹤0.01% |
476,017
+98,578
| +26% | +$7M |
|
|
CIVI
2608
DELISTED
Civitas Resources
CIVI
| $28.6M | ﹤0.01% |
1,054,859
-509,097
| -33% | -$14.7M |
|
2609
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $28.5M | ﹤0.01% |
685,147
-10,562
| -2% | -$440K |
|
2610
Amylyx Pharmaceuticals
AMLX
$2.5B
| $28.5M | ﹤0.01% |
2,359,824
+409,523
| +21% | +$5.56M |
|
2611
TriMas Corp
TRS
$1.39B
| $28.5M | ﹤0.01% |
803,428
+569,083
| +243% | +$19.9M |
|
2612
Innoviva
INVA
$1.5B
| $28.4M | ﹤0.01% |
1,418,739
-6,874
| -0.5% | -$134K |
|
2613
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $28.3M | ﹤0.01% |
1,241,871
-72,552
| -6% | -$1.63M |
|
2614
Intercorp Financial Services
IFS
$6.04B
| $28.3M | ﹤0.01% |
668,685
+248,283
| +59% | +$10.2M |
|
2615
First Trust RiverFront Dynamic Developed International ETF
RFDI
$168M
| $28.3M | ﹤0.01% |
351,570
-464
| -0.1% | -$36.3K |
|
2616
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.41B
| $28.2M | ﹤0.01% |
293,292
+41,469
| +16% | +$3.91M |
|
|
NVMI
2617
Nova
NVMI
$13.1B
| $28.2M | ﹤0.01% |
85,832
+5,001
| +6% | +$1.61M |
|
|
NML
2618
Neuberger Energy Infrastructure and Income Fund Inc
NML
$607M
| $28.2M | ﹤0.01% |
3,315,764
-61,316
| -2% | -$515K |
|
|
FOUR.PRA
2619
Shift4 Payments Inc 6.00% Series A Preferred Stock
FOUR.PRA
$615M
| $28.2M | ﹤0.01% |
352,242
+310,369
| +741% | +$27.2M |
|
2620
Dine Brands
DIN
$440M
| $28.2M | ﹤0.01% |
876,049
+596,413
| +213% | +$17.3M |
|
2621
Axcelis
ACLS
$4.42B
| $28.1M | ﹤0.01% |
350,220
-103,867
| -23% | -$8.7M |
|
2622
American Beacon GLG Natural Resources ETF
MGNR
$908M
| $28.1M | ﹤0.01% |
637,778
+625,875
| +5,258% | +$26.2M |
|
2623
Nuveen Core Plus Impact Fund
NPCT
$284M
| $28.1M | ﹤0.01% |
2,761,229
-117,348
| -4% | -$1.24M |
|
2624
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.08B
| $28M | ﹤0.01% |
495,219
+90,460
| +22% | +$5.06M |
|
2625
Vanguard Russell 2000 Value ETF
VTWV
$1.38B
| $28M | ﹤0.01% |
175,277
+3,607
| +2% | +$571K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.